PUNIT DHILLON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PUNIT DHILLON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PUNIT DHILLON. PUNIT DHILLON is a VP, Finance & Operations in INOVIO PHARMACEUTICALS, INC. ($GEB) and a Director in ONCOSEC MEDICAL Inc ($ONCS) and a President in ONCOSEC MEDICAL Inc ($ONCS) and a President and CEO in ONCOSEC MEDICAL Inc ($ONCS.D) and a CEO in Emerald Bioscience, Inc. ($NMUS) and a Director in Nemus Bioscience, Inc. ($NMUS) and a Director in Arch Therapeutics, Inc. ($ARTH).
Address: 11494 SORRENTO VALLEY RD SAN DIEGO 92121-1318 CA
Companies in which PUNIT DHILLON is an Insider
Arch Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PUNIT DHILLON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 23 2019
$ARTH Market Capitalization: $92.55M
$ARTH Previous Close: $0.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INOVIO PHARMACEUTICALS, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PUNIT DHILLON: VP, Finance & Operations
Holdings: 0 shares
Latest Transaction: Oct 02 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ONCOSEC MEDICAL Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PUNIT DHILLON: Director, President and CEO
Holdings: 355,702 shares
Current Value: $409,057
Latest Transaction: Jan 04 2019
$ONCS Market Capitalization: $22.69M
$ONCS Previous Close: $1.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Skye Bioscience, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PUNIT DHILLON: CEO, Director
Holdings: 1,000,000 shares
Current Value: $460,000
Latest Transaction: Aug 11 2020
$NMUS Market Capitalization: $8.53M
$NMUS Previous Close: $0.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PUNIT DHILLON
Sentiment: All, ARTH, GEB, ONCS, NMUS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11 2020 | NMUS | Emerald Bioscience ... | DHILLON PUNIT | CEO | Option Exercise | A | 0.05 | 9,000,000 | 405,000 | 9,200,000 | |
| Aug 11 2020 | NMUS | Emerald Bioscience ... | DHILLON PUNIT | CEO | Buy | P | 100,000.00 | 1,000,000 | 100,000,000,000 | 1,000,000 | 0 to 1000 K |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.23 | 300,000 | 68,760 | 300,000 | |
| Jan 04 2019 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Option Exercise | A | 0.66 | 50,000 | 32,750 | 50,000 | |
| Oct 12 2018 | NMUS | Nemus Bioscience, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.31 | 200,000 | 61,000 | 200,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.43 | 200,000 | 85,000 | 200,000 | |
| Jul 06 2018 | ONCS | ONCOSEC MEDICAL In ... | DHILLON PUNIT | Director | Option Exercise | M | 0.00 | 200,000 | 0 | 0 |